Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Published Online: 2012-10-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Arturo Molina•Christopher J Logothetis•Christopher M Haqq•Cora N Sternberg•Fred Saad•Howard I Scher•Jin Hui Li•Johann S de Bono•John N Staffurth•Karim Fizazi•Kim N Chi•Nicholas J Vogelzang•Oscar B Goodman•Paul Mainwaring•Robert J Jones•Scott North•Stephen Harland•Thian Kheoh
